Human-Computer Interaction Resource Network
| XOMA | |
| XOMA Ltd. (Nasdaq: XOMA) is a biotechnology company focused on the discovery, development and manufacturing of monoclonal antibody-based therapeutics for unmet medical needs. |
| Last Update : | 04/January/2012 |
| Google PR : | N/A |
| Internal links : | 6 |
| External links : | 9 |
| Archive : | Check how did the site look in the past? |
| Site IP address : | 198.171.10.47 |
| Server type : | Apache/1.3.42 (Unix) mod_auth_tkt/2.1.0 FrontPage/5.0.2.2635 mod_ssl/2.8.31 OpenSSL/0.9.8r |
| Powered by : | ASP.NET |
| DNS 1 : | ns1-auth.sprintlink.net |
| DNS 2 : | ns2-auth.sprintlink.net |
| DNS 3 : | ns3-auth.sprintlink.net |
| DNS 4 : | ns.xoma.com |
| DNS 5 : | ns2.xoma.com |
| MX Domain 1 : | mail2.xoma.com |
| MX Domain 2 : | mail1.xoma.com |
| Alexa rank : | 3,128,683 |
| Description : | Xoma.com has a three-month global Alexa traffic rank of 3,277,137. The site belongs to the “Research and Development” category. The site has been online for more than sixteen years. The site is based in the US. |
| oxoma | 15.66% |
| xoma | 15.29% |
| xoma seventh | 10.18% |
| xoma technology | 9.87% |
| xoma 2910 | 9.77% |
| fred kurland | 7.99% |
| xoma address | 7.99% |
| xoma 052 diabetes | 4.67% |
| xmeta diabetes | 3.82% |
| xoma-052 phase 2 trial initiated in diabetes patients- xoma | 3.13% |
|
|
|
|
|
|